Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results
选择性PPARδ激动剂Seladelpar治疗原发性胆汁性胆管炎的长期疗效和安全性:ASSURE中期研究结果
期刊:American Journal of Gastroenterology
影响因子:7.6
doi:10.14309/ajg.0000000000003603
Levy, Cynthia; Trivedi, Palak J; Kowdley, Kris V; Gordon, Stuart C; Bowlus, Christopher L; Londoño, Maria Carlota; Hirschfield, Gideon M; Gulamhusein, Aliya; Lawitz, Eric J; Vierling, John M; Mayo, Marlyn J; Jacobson, Ira M; Kremer, Andreas E; Corpechot, Christophe; Jones, David; Buggisch, Peter; Zhuo, Shuqiong; Proehl, Sarah; Heusner, Carrie; McWherter, Charles A; Crittenden, Daria B